New drug combinations drive growth, Bristol-Myers Squibb (BMY.US) Q3 results exceed expectations
智通财经2026/10/29 11:37Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
According to Zhitong Finance APP, before the U.S. stock market opened on Thursday, Bristol Myers Squibb (BMY.US) released its financial report for the third quarter of 2026. Thanks to the continued strong performance of its "growth portfolio" products, the company's Q3 results exceeded expectations and it raised its full-year revenue guidance.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Crypto prices
More
Bitcoin
BTC
$77,966.39
-2.48%
Ethereum
ETH
$2,229.26
-3.64%
Tether USDt
USDT
$0.9984
-0.04%
BNB
BNB
$705.18
-6.11%
XRP
XRP
$1.25
-3.01%
USDC
USDC
$0.9997
-0.01%
Solana
SOL
$97.01
-2.92%
TRON
TRX
$0.3330
+0.60%
Hyperliquid
HYPE
$91.42
+15.82%
Zcash
ZEC
$1,244.6
+0.08%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now